Streptococcus suis Infections in Humans: What is the prognosis for Western countries? (Part I)

Clinical Microbiology Newsletter

Volumn 32, Issue 12, 2010, Pages 89-96

  Gottschalk, Marcelo ^a   Xu, Jiangu ^b   Lecours, Marie Pier ^a   Grenier, Daniel ^c   Fittipaldi, Nahuel ^a,d   Segura, Mariela ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b National Institute for Communicable Disease Control and Prevention   (China)

^c UNIVERSITÉ LAVAL   (Canada)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ARACHIDONIC ACID; BACTERIAL POLYSACCHARIDE; CD14 ANTIGEN; DEXAMETHASONE; GAMMA INTERFERON; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN E2; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; BACTERIAL PERITONITIS; BACTERIAL VIRULENCE; CELLULITIS; CHINA; CLINICAL TRIAL; ENDOPHTHALMITIS; EPIDEMIC; HUMAN; INCIDENCE; INFLAMMATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RHABDOMYOLYSIS; SEASONAL VARIATION; SEPTIC SHOCK; SPONDYLITIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS SUIS; SWINE; TOXIC SHOCK SYNDROME; UVEITIS; ZOONOSIS;

EID: 77953498831     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2010.05.005     Document Type: Article

References (112)

1. Higgins R., Gottschalk M. Streptococal diseases. Diseases of swine 2006, 769-783. Iowa State University, Ames, IA. B.E. Straw (Ed.).
2. Devriese L.A., et al. Streptococcus suis infections in birds. Avian Pathol. 1994, 23:721-724.
3. Devriese L.A., Haesebrouck F. Streptococcus suis infections in horses and cats. Vet. Rec. 1992, 130:380.
4. Devriese L.A., et al. Streptococcus suis meningitis in a horse. Vet. Rec. 1990, 127:68.
5. Arends J.P., Zanen H.C. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 1988, 10:131-137.
6. Gottschalk M., et al. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen?. Future Microbiol. 2010, 5:371-391.
7. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 2002, 15:613-630.
8. de la Hoz Adame M.E., et al. Acute meningitis caused by Streptococcus suis: review of a case in a splenectomized patient. Ann. Med. Inter. 2005, 22:507.
9. Tarradas C., et al. Epidemiological relationship of human and swine Streptococcus suis isolates. J. Vet. Med. B Infect. Dis. Vet. Pub. Health 2001, 48:347-355.
10. de Moor C.E. Septicaemic infections in pigs caused by haemolytic streptococci of new Lancefield groups designated R, S and T. Antonie van Leeuwenhoek J. Microbiol. Serol. 1963, 29:272-280.
11. Elliot S.D., McCarty M., Lancefield R.C. Teichoic acids of group D streptococci with special reference to strains from pig meningitis. J. Exp. Med. 1977, 145:490-499.
12. Elliott S.D., Tai J.Y. The type-specific polysaccharides of Streptococcus suis. J. Exp. Med. 1978, 148:1699-1704.
13. Perch B., Pedersen K.B., Henrichsen J. Serology of capsulated streptococci pathogenic for pigs: six new serotypes of Streptococcus suis. J. Clin. Microbiol. 1983, 17:993-996.
14. Gottschalk M., et al. Description of 14 new capsular types of Streptococcus suis. J. Clin. Microbiol. 1989, 27:2633-2636.
15. Chatellier S., et al. Relatedness of Streptococcus suis serotype 2 isolates from different geographic origins as evaluated by molecular fingerprinting and phenotyping. J. Clin. Microbiol. 1999, 37:362-366.
16. Brousseau R., et al. Streptococcus suis serotypes characterized by analysis of chaperonin 60 gene sequences. Appl. Environ. Microbiol. 2001, 67:4828-4833.
17. Galina L., Collins J.E., Pijoan C. Porcine Streptococcus suis in Minnesota. J. Vet. Diagn. Invest. 1992, 4:195-196.
18. Reams R.Y., et al. Multiple serotypes and strains of Streptococcus suis in naturally infected swine herds. J. Vet. Diagn. Invest. 1996, 8:119-121.
19. Higgins R., Gottschalk M. Distribution of Streptococcus suis capsular types in 2000. Can. Vet. J. 2001, 42:223.
20. Kataoka Y., et al. The epidemiological studies of Streptococcus suis infections in Japan from 1987 to 1991. J. Vet. Med. Sci. 1993, 55:623-626.
21. Messier S., Lacouture S., Gottschalk M. Distribution of Streptococcus suis capsular types from 2001 to 2007. Can. Vet. J. 2008, 49:461-462.
22. Fittipaldi N., et al. Serotype distribution and production of muramidase-released protein, extracellular factor and suilysin by field strains of Streptococcus suis isolated in the United States. Vet. Microbiol. 2009, 139:310-317.
23. Wisselink H.J., et al. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet. Microbiol. 2000, 74:237-248.
24. Lun Z.R., et al. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect. Dis. 2007, 7:201-219.
25. Huang Y.T., et al. Streptococcus suis infection. J. Microbiol. Immunol. Infect. 2005, 38:306-313.
26. Wertheim H.F., et al. Streptococcus suis: an emerging human pathogen. Clin. Infect. Dis. 2009, 48:617-625.
27. Suankratay C., et al. Streptococcus suis meningitis in Thailand. Southeast Asian J. Trop. Med. Public Health 2004, 35:868-876.
28. Fongcom A., et al. Streptococcus suis infection in northern Thailand. J. Med. Assoc. Thai. 2001, 84:1502-1508.
29. Navacharoen N., et al. Hearing and vestibular loss in Streptococcus suis infection from swine and traditional raw pork exposure in northern Thailand. J. Laryngol. Otol. 2009, 123:857-862.
30. Kay R., Cheng A.F., Tse C.Y. Streptococcus suis infection in Hong Kong. Q.J.M. 1995, 88:39-47.
31. Lutticken R., et al. Meningitis caused by Streptococcus suis: case report and review of the literature. Infection 1986, 14:181-185.
32. Walsh B., Williams A.E., Satsangi J. Streptococcus suis type 2: pathogenesis and clinical disease. Rev. Med. Microbiol. 1992, 3:65-71.
33. Normile D. Infectious diseases. WHO probes deadliness of China's pig-borne disease. Science 2005, 309:1308-1309.
34. Yu H., et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 2006, 12:914-920.
35. Tang J., et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med. 2006, 3:151.
36. Hashikawa S., et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J. Clin. Microbiol. 2004, 42:186-192.
37. Yang Q.P., et al. Autopsy report of four cases who died from Streptococcus suis infection, with a review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:447-453.
38. Ma Y., et al. Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364:2725-2737.
39. Zhu F., et al. Homogeneity study on the Streptococcus suis isolated from human and swine. Zhonghua Liu Xing Bing Xue Za Zhi 2000, 21:427-429.
40. Pedroli S., et al. Streptococcus suis bacteremia. Presse Med. 2003, 32:599-601.
41. Kopic J., Paradzik M.T., Pandak N. Streptococcus suis infection as a cause of severe illness: 2 cases from Croatia. Scand. J. Infect. Dis. 2002, 34:683-684.
42. van Jaarsveld B.C., et al. Fulminant sepsis caused by Streptococcus suis. Ned. Tijdschr. Geneeskd. 1990, 134:1462-1464.
43. Strangmann E., Froleke H., Kohse K.P. Septic shock caused by Streptococcus suis: case report and investigation of a risk group. Int. J. Hyg. Environ. Health 2002, 205:385-392.
44. Bungener W., Bialek R. Fatal Streptococcus suis septicemia in an abattoir worker. Eur. J. Clin. Microbiol. Infect. Dis. 1989, 8:306-308.
45. Francois B., et al. Recurrent septic shock due to Streptococcus suis. J. Clin. Microbiol. 1998, 36:2395.
46. Wangsomboonsiri W., et al. Streptococcus suis infection and risk factors for mortality. J. Infect. 2008, 57:392-396.
47. Tramontana A.R., et al. An Australian case of Streptococcus suis toxic shock syndrome associated with occupational exposure to animal carcasses. Med. J. Aust. 2008, 188:538-539.
48. Takamatsu D., et al. Streptococcus suis in humans, Thailand. Emerg. Infect. Dis. 2008, 14:181-183.
49. Wangkaew S., et al. Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J. Infect. 2006, 52:455-460.
50. Watkins E.J., et al. Septicemia in a pig-farm worker. Lancet 2001, 357:38.
51. Baums C.G., Valentin-Weigand P. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim. Health Res. Rev. 2009, 10:65-83.
52. Smith H.E., et al. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 1999, 67:1750-1756.
53. Charland N., et al. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology 1998, 144:325-332.
54. Gottschalk M., Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 2000, 76:259-272.
55. Gottschalk M., Segura M., Xu J. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 2007, 8:29-45.
56. Takamatsu D., et al. Genetic organization and preferential distribution of putative pilus gene clusters in Streptococcus suis. Vet. Microbiol. 2009, 138:132-139.
57. Fittipaldi N., et al. Use of selective capture of transcribed sequences to identify genes preferentially expressed by Streptococcus suis upon interaction with porcine brain microvascular endothelial cells. Appl. Environ. Microbiol. 2007, 73:4359-4364.
58. Fittipaldi N., et al. Mutations in the gene encoding the ancillary pilin subunit of the Streptococcus suis srtF cluster result in pili formed by the major subunit only. PLoS One 2010, 5:8426.
59. Garibaldi M., et al. Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. Vaccine 2010, 28:3609-3610.
60. Osaki M., et al. Allelic variation in srtAs of Streptococcus suis strains. FEMS Microbiol. Lett. 2003, 219:195-201.
61. Vanier G., et al. Disruption of srtA gene in Streptococcus suis results in decreased interactions with endothelial cells and extracellular matrix proteins. Vet. Microbiol. 2008, 127:417-424.
62. Wang C., et al. The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Arch. Microbiol. 2009, 191:23-33.
63. Grenier D., et al. The cell envelope subtilisin-like proteinase is a virulence determinant for Streptococcus suis. BMC Microbiol 2010, 10:42.
64. Benga L., et al. Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes. Vet. Microbiol. 2008, 132:211-219.
65. Chabot-Roy G., et al. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 2006, 41:21-32.
66. Charland N., et al. Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect. Immun. 2000, 68:637-643.
67. Lalonde M., et al. Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology 2000, 146:1913-1921.
68. Segura M., Gottschalk M. Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect. Immun. 2002, 70:4312-4322.
69. Segura M., et al. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 2006, 47:92-106.
70. Smith H.E., et al. Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs. Infect. Immun. 1996, 64:4409-4412.
71. Vecht U., et al. Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect. Immun. 1991, 59:3156-3162.
72. Silva L.M., et al. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet. Microbiol. 2006, 115:117-127.
73. Gottschalk M.G., Lacouture S., Dubreuil J.D. Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 1995, 141:189-195.
74. Jacobs A.A., et al. Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect. Immun. 1994, 62:1742-1748.
75. Allen A.G., et al. Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect. Immun. 2001, 69:2732-2735.
76. Lun S., et al. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb. Pathog. 2003, 34:27-37.
77. Wei Z., et al. Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. Vet. Microbiol. 2009, 137:196-201.
78. Galina L., et al. Prevalence of various phenotypes of Streptococcus suis isolated from swine in the U.S.A. based on the presence of muraminidase-released protein and extracellular factor. Can. J. Vet. Res. 1996, 60:72-74.
79. Gottschalk M., et al. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can. J. Vet. Res. 1998, 62:75-79.
80. Berthelot-Herault F., et al. Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France. Vet. Res. 2000, 31:473-479.
81. Segers R.P., et al. Characterisation of the gene encoding suilysin from Streptococcus suis and expression in field strains. FEMS Microbiol. Lett. 1998, 167:255-261.
82. Takamatsu D., et al. Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population. J. Med. Microbiol. 2008, 57:488-494.
83. Quessy S., Dubreuil J.D., Higgins R. Immunization of mice against Streptococcus suis serotype 2 infections using a live avirulent strain. Can. J. Vet. Res. 1994, 58:299-301.
84. Madsen L.W., et al. Bacterial colonization and invasion in pigs experimentally exposed to Streptococcus suis serotype 2 in aerosol. J. Vet. Med. B Infect. Dis. Vet. Public Health 2002, 49:211-215.
85. Norton P.M., et al. Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin. FEMS Immunol. Med. Microbiol. 1999, 26:25-35.
86. Valentin-Weigand P. Intracellular invasion and persistence: survival strategies of Streptococcus suis and Mycobacterium avium ssp. paratuberculosis. Berl. Munch. Tierarztl. Wochenschr. 2004, 117:459-463.
87. Benga L., et al. Non-encapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells. Cell. Microbiol. 2004, 6:867-881.
88. Van Calsteren M.-R., et al. Structure determination of Streptococcus suis serotype 2 capsular polysaccharide. Biochim. Biol. Cell. 2010, in press.
89. Lecours, M.-P. et al. 2009. Streptococcus suis cell wall components and suilysin modulate dendritic cells functions. Presented at Conference of Research Workers in Animal Diseases, Chicago, IL, 6-8 December 2009.
90. Benga L., Friedl P., Valentin-Weigand P. Adherence of Streptococcus suis to porcine endothelial cells. J. Vet. Med. B Infect. Dis. Vet. Public Health 2005, 52:392-395.
91. Vanier G., et al. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect. Immun. 2004, 72:1441-1449.
92. Tenenbaum T., et al. Cell death, caspase activation, and HMGB1 release of porcine choroid plexus epithelial cells during Streptococcus suis infection in vitro. Brain Res. 2006, 1100:1-12.
93. Tenenbaum T., et al. Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro. Brain Res. 2008, 1229:1-17.
94. Tenenbaum T., et al. Polar bacterial invasion and translocation of Streptococcus suis across the blood-cerebrospinal fluid barrier in vitro. Cell. Microbiol. 2009, 11:323-336.
95. Tenenbaum T., et al. Strain-dependent disruption of blood-cerebrospinal fluid barrier by Streptoccocus suis in vitro. FEMS Immunol. Med. Microbiol. 2005, 44:25-34.
96. Segura M., Vadeboncoeur N., Gottschalk M. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin. Exp. Immunol. 2002, 127:243-254.
97. Vanier G., et al. New putative virulence factors of Streptococcus suis involved in invasion of porcine brain microvascular endothelial cells. Microb. Pathog. 2009, 46:13-20.
98. Vadeboncoeur N., et al. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 2003, 35:49-58.
99. Segura M., Stankova J., Gottschalk M. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 1999, 67:4646-4654.
100. Graveline R., et al. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int. Immunol. 2007, 19:375-389.
101. Tanabe S., Gottschalk M., Grenier D. Hemoglobin and Streptococcus suis cell wall act in synergy to potentiate the inflammatory response of monocyte-derived macrophages. Innate Immun. 2008, 14:357-363.
102. Dominguez-Punaro M.C., et al. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J. Immunol. 2007, 179:1842-1854.
103. Ye C., et al. Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J. Infect. Dis. 2009, 199:97-107.
104. Dominguez-Punaro M.C., et al. Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection. Infect. Immun. 2008, 76:3901-3910.
105. Jobin M.C., et al. Acquisition of plasmin activity and induction of arachidonic acid release by Streptococcus suis in contact with human brain microvascular endothelial cells. FEMS Microbiol. Lett. 2005, 252:105-111.
106. Jobin M.C., Gottschalk M., Grenier D. Upregulation of prostaglandin E2 and matrix metalloproteinase 9 production by human macrophage-like cells: synergistic effect of capsular material and cell wall from Streptococcus suis. Microb. Pathog. 2006, 40:29-34.
107. Tanabe S., Grenier D. Endothelial cell/macrophage cocultures as a model to study Streptococcus suis-induced inflammatory responses. FEMS Immunol. Med. Microbiol. 2009, 55:100-106.
108. Al-Numani D., et al. Up-regulation of ICAM-1, CD11a/CD18 and CD11c/CD18 on human THP-1 monocytes stimulated by Streptococcus suis serotype 2. Clin. Exp. Immunol. 2003, 133:67-77.
109. Grenier D., Bodet C. Streptococcus suis stimulates ICAM-1 shedding from microvascular endothelial cells. FEMS Immunol. Med. Microbiol. 2008, 54:271-276.
110. Wichgers Schreur P.J., et al. Differential activation of the Toll-like receptor 2/6 complex by lipoproteins of Streptococcus suis serotypes 2 and 9. Vet. Microbiol 2009, in press.
111. Mai N.T., et al. Streptococcus suis meningitis in adults in Vietnam. Clin. Infect. Dis. 2008, 46:659-667.
112. Nguyen T.H., et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N. Engl. J. Med. 2007, 357:2431-2440.